Gary Wilcox
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gary Wilcox
Earlier roles on record: CEO at Cocrystal Pharma, Inc. (COCP) until May 26, 2021. The proxy statement of Cocrystal Pharma, Inc. reports total compensation of $131,250 for Gary Wilcox in fiscal 2021, including a base salary of $131,250. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2021-05-26
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Cocrystal Pharma, Inc. (COCP) | Former Chief Executive Officer | $131,250 | $131,250 |
| 2020 | Cocrystal Pharma, Inc. (COCP) | Former Chief Executive Officer | $268,000 | $563,000 |
| 2019 | Cocrystal Pharma, Inc. (COCP) | Chief Executive Officer | $201,000 | $201,000 |
| 2018 | Cocrystal Pharma, Inc. (COCP) | Chief Executive Officer | $136,952 | $558,352 |
Recent activity
No call appearances or filed executive changes recorded yet.